Skip to main content
. 2022 Aug 4;140(5):419–437. doi: 10.1182/blood.2021012057

Table 3.

Clonality assessment methods

Assessment method
For CTCL, T-cell clonality can be established by one of the following molecular methods
 BIOMED-2 or other PCR-based, approved protocol for both  TCR-γ and TCR-β gene rearrangement
 Next generation sequencing (high-throughput sequencing)
For CBCL, B-cell clonality can be established by one of the following molecular methods
 BIOMED-2 protocol or other PCR-approved method for  immunoglobulin heavy chain (IgH) and/or Igκ  rearrangement
 Surface or cytoplasmic light chains restriction by flow cytometry  (peripheral blood or tissue samples)
 Monotypic surface light chains restriction by  immunohistochemistry (κ and λ immunostain)
 Light chains restriction by conventional or RNA-scope  ultrasensitive in situ hybridization
 IgH rearrangement by next generation sequencing for IgH or  Igκ